Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Which Genes for Hereditary Breast Cancer?
Narod SA. Narod SA. N Engl J Med. 2021 Feb 4;384(5):471-473. doi: 10.1056/NEJMe2035083. Epub 2021 Jan 20. N Engl J Med. 2021. PMID: 33471975 No abstract available.
Is hereditary site-specific ovarian cancer a distinct genetic condition?
Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD. Liede A, et al. Among authors: narod sa. Am J Med Genet. 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r. Am J Med Genet. 1998. PMID: 9450858
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.
Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA. Brunet JS, et al. Among authors: narod sa. J Natl Cancer Inst. 1998 May 20;90(10):761-6. doi: 10.1093/jnci/90.10.761. J Natl Cancer Inst. 1998. PMID: 9605646
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.
Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Jernström H, et al. Among authors: narod sa. Lancet. 1999 Nov 27;354(9193):1846-50. doi: 10.1016/s0140-6736(99)04336-6. Lancet. 1999. PMID: 10584720 Free article.
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaffe MJ, Goel V, Ramsay E, Chart PL, Cole DE, Taylor GA, Cutrara M, Samuels TH, Murphy JP, Murphy JM, Narod SA. Warner E, et al. Among authors: narod sa. J Clin Oncol. 2001 Aug 1;19(15):3524-31. doi: 10.1200/JCO.2001.19.15.3524. J Clin Oncol. 2001. PMID: 11481359
888 results